How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015-2021.

Julian Perelman,Filipa Duarte-Ramos, António Melo Gouveia,Luis Pinheiro, Francisco Ramos,Sabine Vogler,Céu Mateus

Expert review of pharmacoeconomics & outcomes research（2023）

引用 2|浏览9

暂无评分

摘要

The findings suggest a need for capacity-building on biosimilar prescribing, including for doctors of academic hospitals and those working in settings where high biosimilar use would be expected.

查看译文

关键词

Biosimilar,Portugal,diffusion,hospital-related determinants,intra-country differences,savings,uptake

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要